Merck Sharp & Dohme

Merck Sharp & Dohme. Merck Sharp & Dohme is the global human health division of the American pharmaceutical giant Merck & Co., operating outside the United States and Canada. The name originates from the 1953 merger between Merck & Co. and the Philadelphia-based drug firm Sharp & Dohme, which significantly expanded Merck's international distribution network. Today, it is a leading research-driven organization focused on discovering, developing, and marketing a wide range of prescription medicines and vaccines for challenging diseases worldwide.

History

The lineage of Merck Sharp & Dohme begins with the separate founding of its two namesake companies. Merck & Co. was established in 1891 as the American subsidiary of the German Merck Group, later becoming independent during World War I. Concurrently, Alpheus Phineas Sharp and Carl Friedrich Louis Dohme founded Sharp & Dohme in Baltimore in 1845, which grew into a major pharmaceutical distributor. The pivotal merger in 1953, orchestrated by Merck & Co. CEO John J. Horan, was a strategic move to combine Merck's robust research capabilities with Sharp & Dohme's extensive marketing and supply chain. This integration facilitated rapid international expansion, with the Merck Sharp & Dohme name becoming the standard for the company's operations in regions like Europe, Asia, and Latin America. Key acquisitions, such as that of the Swedish company AB Astra's pharmaceutical business in the 1990s, further solidified its global footprint.

Products and research

The portfolio of Merck Sharp & Dohme includes several blockbuster drugs and vaccines that have transformed medical practice. Its research efforts, heavily centered at facilities like the Merck Research Laboratories in Rahway, New Jersey, have yielded critical therapies in oncology, immunology, and infectious diseases. Notable products include Keytruda (pembrolizumab), an immuno-oncology drug used to treat various cancers including melanoma and non-small cell lung carcinoma, and Gardasil, a vaccine for the prevention of infections caused by human papillomavirus. Other significant contributions include Januvia for type 2 diabetes, the antiretroviral drug Isentress for HIV/AIDS, and the Ebola vaccine Ervebo. The division maintains extensive research collaborations with institutions like the Wellcome Trust and engages in ongoing clinical trials across the globe.

Corporate affairs

As the international division of Merck & Co., Merck Sharp & Dohme operates within a complex global corporate structure, with its headquarters for the division often cited in Rahway, New Jersey. It manages a vast commercial infrastructure encompassing manufacturing plants, distribution centers, and regulatory affairs offices in over 140 countries. The organization is a major participant in global health initiatives, frequently partnering with entities such as the World Health Organization, the Bill & Melinda Gates Foundation, and Gavi, the Vaccine Alliance to improve access to medicines in the developing world. Its operations are a significant component of the financial performance of the parent company, contributing substantially to annual revenue reported to the U.S. Securities and Exchange Commission.

Legal and regulatory issues

Like many large pharmaceutical entities, Merck Sharp & Dohme has faced numerous legal challenges and regulatory scrutiny across multiple jurisdictions. This has included high-profile product liability litigation, such as cases involving the COX-2 inhibitor Vioxx, which was withdrawn from the global market in 2004. The division has also been subject to investigations by regulatory bodies like the European Medicines Agency and the U.S. Food and Drug Administration over drug safety and marketing practices. Settlements with governments, including the U.S. Department of Justice, have addressed allegations related to off-label promotion and violations of the False Claims Act. Furthermore, it has navigated complex intellectual property disputes, including patent challenges related to Keytruda in courts from the United Kingdom to Australia.

See also

* Merck & Co. * Pharmaceutical industry * Keytruda * Gardasil * Vioxx * Clinical trial

Category:Merck & Co. Category:Pharmaceutical companies of the United States Category:Companies based in New Jersey